These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8009690)

  • 41. Enzyme-linked immunosorbent assay of apolipoprotein B in blood spotted onto filter paper, suitable for neonatal screening.
    Wang XL; Dudman NP; Wilcken DE
    Clin Chem; 1989 Jun; 35(6):1000-4. PubMed ID: 2499430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for familial hypercholesterolemia in 5000 neonates: a recall study.
    Blades BL; Dudman NP; Wilcken DE
    Pediatr Res; 1988 May; 23(5):500-4. PubMed ID: 3387172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pinpoint skin lesions in a familial hypercholesterolaemia homozygote.
    Milionis HJ; Miltiadous GA; Cariolou M; Elisaf MS
    Acta Paediatr; 2003 Sep; 92(9):1109-10. PubMed ID: 14599079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies.
    Martin AC; Bell DA; Brett T; Watts GF
    Curr Opin Lipidol; 2017 Aug; 28(4):321-327. PubMed ID: 28426524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Documenting family history in children with hypercholesterolaemia: A lost opportunity.
    Sorubarajan T; Lewis BD; Burnett JR; Martin AC
    J Paediatr Child Health; 2017 May; 53(5):470-473. PubMed ID: 28045210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholesterol levels in children: to screen or not to screen.
    Purcell AC; O'Brien E; Parks PL
    J Pediatr Nurs; 1996 Feb; 11(1):40-4. PubMed ID: 8867220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.
    Wald DS; Bestwick JP; Wald NJ
    BMJ; 2007 Sep; 335(7620):599. PubMed ID: 17855284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Machine learning modelling of blood lipid biomarkers in familial hypercholesterolaemia versus polygenic/environmental dyslipidaemia.
    Correia M; Kagenaar E; van Schalkwijk DB; Bourbon M; Gama-Carvalho M
    Sci Rep; 2021 Feb; 11(1):3801. PubMed ID: 33589716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Referral Patterns and Cascade Screening for Familial Hypercholesterolemia in a Pediatric Lipid Clinic.
    Stempel H; Dodge A; Marriott E; Peterson AL
    J Pediatr; 2016 Nov; 178():285-287. PubMed ID: 27592098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care.
    Weng S; Kai J; Akyea R; Qureshi N
    Lancet Public Health; 2019 May; 4(5):e256-e264. PubMed ID: 31054643
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for hypercholesterolaemia in 10,000 neonates in a multi-ethnic population.
    Beeso J; Wong N; Ayling R; Eldridge P; Marshall W; Sherwood R; Peters T
    Eur J Pediatr; 1999 Oct; 158(10):833-7. PubMed ID: 10486088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved stability of apolipoproteins A-I and B in filter-paper blood spots impregnated with ascorbic acid.
    Micic S; Nørgaard-Pedersen B
    Clin Chem; 1995 Jul; 41(7):1042-3. PubMed ID: 7600686
    [No Abstract]   [Full Text] [Related]  

  • 53. Paediatric screening for hypercholesterolaemia in Europe.
    Kusters DM; de Beaufort C; Widhalm K; Guardamagna O; Bratina N; Ose L; Wiegman A
    Arch Dis Child; 2012 Mar; 97(3):272-6. PubMed ID: 21949015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neonatal screening for familial hypercholesterolaemia by immunoturbidimetric assay of apolipoprotein B in dried blood spots.
    Bangert SK; Eldridge PH; Peters TJ
    Clin Chim Acta; 1992 Dec; 213(1-3):95-101. PubMed ID: 1477991
    [No Abstract]   [Full Text] [Related]  

  • 55. Detecting familial hypercholesterolaemia in general practice.
    Kirke A; Watts GF; Emery J
    Aust Fam Physician; 2012 Dec; 41(12):965-8. PubMed ID: 23210121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Familial hypercholesterolaemia and primary hypothyroidism: coexistence of both disorders in a young woman with severe hypercholesterolaemia.
    Illingworth DR; McClung MR; Connor WE; Alaupovic P
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):145-52. PubMed ID: 7261412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for familial hypercholesterolaemia in primary school children: protocol for a cross-sectional, feasibility study in Luxembourg city (EARLIE).
    Becker M; Adamski A; Fandel F; Vaillant M; Wagner K; Droste DW; Ziade B; Hein S; Mendon P; Bocquet V; de Beaufort C
    BMJ Open; 2022 Dec; 12(12):e066067. PubMed ID: 36600332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neonatal screening for hypercholesterolaemia.
    Lancet; 1987 Aug; 2(8553):273-4. PubMed ID: 2886738
    [No Abstract]   [Full Text] [Related]  

  • 59. Screening for familial hypercholesterolaemia in relatives.
    Tonstad S; Vollebaek LE; Ose L
    Lancet; 1995 Nov; 346(8987):1438. PubMed ID: 7475864
    [No Abstract]   [Full Text] [Related]  

  • 60. A neonatal screening approach to the detection of familial hypercholesterolaemia and family-based coronary prevention.
    Wilcken DE; Blades BL; Dudman NP
    J Inherit Metab Dis; 1988; 11 Suppl 1():87-90. PubMed ID: 3141689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.